GT Biopharma Net Non-Operating Interest Income Expense (Quarterly) Analysis

GT Biopharma, Inc. (GTBP)

0.7027 -0.02 (-3.12%) USD | NASDAQ | Jan 21, 16:00

0.68 -0.02 (-3.23%) After-Hours: 17:06

View Net Non-Operating Interest Income Expense (Quarterly) for GTBP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

SELLAS Life Sciences Group, Inc.	Upgrade
Lyell Immunopharma, Inc.	Upgrade
Geron Corp.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Xencor, Inc.	Upgrade